Influence of methacrylic acid and hydroxypropylmethyl cellulose on the tablet properties and in vitro release of dextromethorphan hydrobromide

Pharmazie

Volumn 58, Issue 12, 2003, Pages 886-890

  Takka, Sevgi ^a   Bharaj, S Singh ^b   Sakr, A ^b  

^a GAZI UNIVERSITY   (Turkey)

^b UNIVERSITY OF CINCINNATI   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DEXTROMETHORPHAN; EUDRAGIT; HYDROXYPROPYLMETHYLCELLULOSE; METHACRYLIC ACID; METHOCEL K 100 LV; POLYMER;

ARTICLE; CONCENTRATION RESPONSE; CRUSHING STRENGTH; DRUG RELEASE; EVALUATION; PHYSICAL CHEMISTRY; TABLET COMPRESSION; TABLET DISINTEGRATION TIME; TABLET FRIABILITY; TABLET MATRIX; TABLET PROPERTY; TABLET THICKNESS; WEIGHT;

ACRYLIC RESINS; ALGORITHMS; ANTITUSSIVE AGENTS; DEXTROMETHORPHAN; DRUG COMPOUNDING; EXCIPIENTS; HARDNESS; METHACRYLATES; METHYLCELLULOSE; SOLUBILITY; TABLETS;

EID: 0346366658     PISSN: 00317144     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (17)

1. Perez-Marcos, B.; Ford, J. L.; Armstrong, D. J.; Elliot, P. N. C.; Rostron, C.; Hogan, J. E.: Int. J. Pharm. 111, 251 (1994)
2. Nellore, R. V.; Gurvinder, S. R.; Hussain, A. S.; Tillman, L. G.; Augsburger, L. L.: J. Contr. Rel. 50, 247 (1998)
3. Mitchell, K.; Ford, J. L.; Armstrong, D. J.; Elliott, P. N. C.; Hogan, J. E., Rostron, C.: Int. J. Pharm. 100, 165 (1993)
4. Gonzalez, I. M.; Robles, L. V.: Int. J. Pharm. 251, 183 (2003)
5. Hussain, A. S.; Johnson, R. D.; Shivanand, P.; Zoglio, M.A.: Drug Dev. Ind. Pharm. 20, 2645 (1994)
6. Dow Pharmaceutical Excipients, The Dow Chemical Company, Midland, Michagan 1996
7. Vela, M. T.; Fernandez-Hervas, M. J.; Fernandez-Arevalo, M.; Rabasco, A. M.: Farmaco 50, 201 (1995)
8. Cameron, C. G.; McGinity, J. W.: Drug Dev. Ind. Pharm. 13, 1409 (1987)
9. Jovanovic, M.; Jovicic, G.; Duric, Z.; Agbaba, D.; Karlijikovic-Rajic, K.; Radovanovic, J.; Nikolic, L.: Drug Dev. Ind. Pharm. 23, 595 (1997)
10. Dabbagh, M. A.; Ford, J. L.; Rubenstein, M. H.; Hogan, J. E.; RajabiSiahboomi, A. R.: Pharm. Dev. Tech. 4, 313 (1999)
11. Takka, S.; Rajbhandari, S.; Sakr, A.: Eur. J. Pharm. Biopharm. 52, 75 (2001)
12. Plazier, V. J.; Dauwe, D., Brioen, P.: S. T. P. Pharma Sci. 7, 491 (1997)
13. Lilienfield, L. S.; Zapolski, E. J.: Curr. Therap. Res. 33, 692 (1983)
14. Char, H.; Kumar, S.; Patel, S.; Piemontese, D.; Iqbal, K.; Malick, W.; Salvador, R. A.; Behl, C. R.: J. Pharm. Sci. 81, 750 (1992)
15. Demirbas, S.; Reyderman, L.; Stavchansky, S.: Biopharm. Drug Disp. 19, 541 (1998)
16. Gilligan, C. A.; Po, L. W.: Int. J. Pharm. 73, 51 (1991)
17. U.S. Department of Health, Food and Drug Administration. Dissolution Testing of Immediate Release Solid Oral Dosage Forms, August 1997